Depressed phosphatidic acid-induced contractile activity of failing cardiomyocytes

Biochemical and Biophysical Research Communications

Volumn 300, Issue 2, 2003, Pages 457-463

  Tappia, Paramjit S ^a,b   Maddaford, Thane G ^a,b   Hurtado, Cecilia ^a,b   Panagia, Vincenzo ^c   Pierce, Grant N ^a,b  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c NONE

Author keywords

Active cell shortening; Calcium transients; Cardiomyocyte; Congestive heart failure; Phosphatidic acid; Phospholipase C; Phospholipid mediated signaling

Indexed keywords

2 NITRO 4 CARBOXYPHENYL N,N DIPHENYLCARBONATE; CALCIUM ION; INOTROPIC AGENT; PHOSPHATIDIC ACID; PHOSPHOLIPASE C INHIBITOR; UNCLASSIFIED DRUG; CALCIUM; PHOSPHOLIPASE C;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIASTOLE; DRUG RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART CONTRACTION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBER MEMBRANE; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLE; ANIMAL; CELL CULTURE; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; HEART; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; KINETICS; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CALCIUM; CELLS, CULTURED; HEART; HEART FAILURE, CONGESTIVE; KINETICS; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PHOSPHATIDIC ACIDS; PHOSPHOLIPASE C; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR FUNCTION, LEFT;

EID: 0037427498     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02835-8     Document Type: Article

References (37)

1. Panagia V., Ou C., Taira Y., Dai J., Dhalla N.S. Phospholipase D activity in subcellular membranes of rat ventricular myocardium. Biochim. Biophys. Acta. 1064:1991;242-250.
2. Dhalla N.S., Xu Y.-J., Sheu S.S., Tappia P.S., Panagia V. Phosphatidic acid: a potential signal transducer for cardiac hypertrophy. J. Mol. Cell. Cardiol. 29:1997;2865-2871.
3. Meij J.T.A., Panagia V. Ostadal B., Dhalla N.S. Heart Function in Health and Disease. 1993;79-90 Kluwer Academic Publishers, Boston.
4. 2+ and cardiac contractile force Am. J. Physiol. 271:1996;H651-H659.
5. Henry R.A., Boyce S.Y., Kurz T., Wolf R.A. Stimulation and binding of myocardial phospholipase C by phosphatidic acid. Am. J. Physiol. 269:1995;C349-C358.
6. Tappia P.S., Yu C.-H., Di Nardo P., Pasricha A.K., Dhalla N.S., Panagia V. Depressed responsiveness of phospholipase C isozymes to phosphatidic acid in congestive heart failure. J. Mol. Cell. Cardiol. 33:2001;431-440.
7. Yu C.-H., Panagia V., Tappia P.S., Liu S.-Y., Takeda N., Dhalla N.S. Alterations of sarcolemmal phospholipase D and phosphatidate phosphohydrolase in congestive heart failure. Biochim. Biophys. Acta. 1584:2002;65-72.
8. Ju H., Zhao S., Tappia P.S., Panagia V., Dixon I.M.C. Expression of Gq. α and PLC- β in scar and border tissue in heart failure due to myocardial infarction Circulation. 97:1998;892-899.
9. Tappia P.S., Liu S.-Y., Shatadal S., Takeda N., Dhalla N.S., Panagia V. Changes in sarcolemmal PLC isoenzymes in postinfarct congestive heart failure: partial correction by imidapril. Am. J. Physiol. 277:1999;H40-H49.
10. Meij J.T.A., Panagia V., Mesaeli N., Peachell J.L., Afzal N., Dhalla N.S. Identification of changes in cardiac phospholipase C activity in congestive heart failure. J. Mol. Cell. Cardiol. 29:1997;237-246.
11. 2+ transients in isolated rabbit cardiomyocytes. J. Biol. Chem. 268:1993;3767-3775.
12. Maddaford T.G., Hurtado C., Austria J.A., Pierce G.N. A model of low-flow ischemia and reperfusion in single beating cardiomyocytes. Am. J. Physiol. 277:1999;H788-H798.
13. Hongo M., Ryoke T., Ross J. Jr. Animal models of heart failure. Recent developments and perspectives. Trends Cardiovasc. Med. 7:1997;161-167.
14. Zelis R., Clemson B., Baily R., Davis D. Regulation of tissue noradrenaline in the rat myocardial infarction model of chronic heart failure. Cardiovasc. Res. 26:1992;932-938.
15. Xu Y.-J., Rathi S.S., Zhang M., Bhugra P., Dhalla N.S. Mechanisms of the positive inotropic effect of lysophosphatidic acid in rat heart. J. Cardiovasc. Pharmacol. Ther. 7:2002;109-115.
16. Murayama T., Ui M. Phosphatidic acid may stimulate membrane receptors mediating adenylate cyclase inhibition and phospholipid breakdown. J. Biol. Chem. 262:1987;5522-5529.
17. Ohsako S., Deguchi T. Stimulation by phosphatidic acid of calcium influx and cyclic GMP synthesis in neuroblastoma cells. J. Biol. Chem. 256:1981;10945-10948.
18. Pagano R.E., Longmuir K.J. Phosphorylation, transbilayer movement and facilitated intracellular transport of diacylglycerol are involved in the uptake of a fluorescent analogue of phosphatidic acid by cultured fibroblasts. J. Biol. Chem. 260:1985;1909-1916.
19. Nosek T.M., Williams M.F., Zeigler S.T., Godt R.E. Inositol trisphosphate enhances calcium release in skinned cardiac and skeletal muscle. Am. J. Physiol. 250:1986;C807-C811.
20. Dhalla N.S., Afzal N., Beamish R.E., Naimark B., Takeda N., Nagano M. Pathophysiology of cardiac dysfunction in congestive heart failure. Can. J. Physiol. 9:1993;873-887.
21. Dhalla N.S., Temsah R.M., Netticadan T. Role of oxidative stress in cardiovascular diseases. J. Hypertens. 18:2000;655-673.
22. Dixon I.M.C., Hata T., Dhalla N.S. Sarcolemmal calcium transport in congestive heart failure due to myocardial infarction in rats. Am. J. Physiol. 262:1992;H1387-H1394.
23. Kurz T., Wolf R.A., Corr P.B. Phosphatidic acid stimulates inositol 1,4,5-trisphosphate production production in adult cardiac myocytes. Circ. Res. 72:1993;701-706.
24. Gomez A.M., Guatimosim S., Dily K.W., Vassort G., Lederer W.J. Heart failure after myocardial infarction: altered excitation-contraction coupling. Circulation. 104:2001;688-693.
25. Benitah J.P., Kerfant B.G., Vassort G., Richard S., Gomez A.M. Altered communication between L-type calcium channels and ryanodine receptors in heart failure. Front. Biosci. 7:2002;e263-e275.
26. 2 -adrenergic stimulation in heart failure J. Pharmacol. Exp. Ther. 298:2001;188-196.
27. Ca, L in ventricular myocytes from rats with postinfarction CHF Am. J. Physiol. 283:2002;H1225-H1236.
28. Carafoli E. How calcium crosses plasma membrane including the sarcolemmal. Opie L. Calcium Antagonists and Cardiovascular Disease. 1984;29-41 Raven Press, New York.
29. 2+ exchange in cardiac sarcolemmal vesicles by phospholipase D J. Biol. Chem. 259:1984;16-19.
30. 2+ exchange activity of cardiac sarcolemmal in reconstituted vesicles Biochim. Biophys. Acta. 937:1987;258-268.
31. Dhalla N.S., Pierce G.N., Panagia V., Singal P.K., Beamish R.E. Calcium movements in relation to heart function. Basic Res. Cardiol. 77:1982;117-139.
32. Dhalla N.S., Dixon I.M.C., Rupp H., Barwinsky J. Experimental congestive heart failure due to myocardial infarction: sarcolemmal receptors and cation transporters. Basic Res. Cardiol. 86:1991;13-23.
33. Ye H., Wolf R.A., Kurz T., Corr P.B. Phosphatidic acid increases in response to noradrenaline and endothelin-1 in adult rabbit ventricular myocytes. Cardiovasc. Res. 28:1994;1828-1834.
34. Sadoshima J., Izumo S. Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro: roles of phospholipid-derived messengers. Circ. Res. 73:1993;424-438.
35. Homcy C.J., Vatner S.F., Vatner D.E. β -Adrenergic receptor regulation in the heart in pathophysiological states: abnormal adrenergic responsiveness in cardiac disease Annu. Rev. Physiol. 53:1991;137-159.
36. Yamagishi H., Kim S., Nishikimi T., Takeuchi K., Takeda T. Contribution of cardiac renin-angiotensin to ventricular remodeling in myocardial-infarcted rats. J. Mol. Cell. Cardiol. 25:1993;1369-1380.
37. Margulies K.B., Hildebrand F.L., Lerman A., Perella M.A., Burnett J.C. Increased endothelin in experimental heart failure. Circulation. 82:1990;1954-1961.